TRIM13 anticorps (Middle Region)
Aperçu rapide pour TRIM13 anticorps (Middle Region) (ABIN1109332)
Antigène
Voir toutes TRIM13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Séquence
- DTLETSKRKS LQLLTKDSDK VKEFFEKLQH TLDQKKNEIL SDFETMKLAV
-
Réactivité croisée (Details)
- Species reactivity (expected):Rat, Mouse, BovineSpecies reactivity (tested):Human
-
Purification
- Purified using peptide immunoaffinity column
-
Immunogène
- The immunogen for anti-TRIIM13 antibody: synthetic peptide directed towards the middle region of human TRIM13
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Add 50 μL of distilled water to a final concentration of 1 mg/mL.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
-
- TRIM13 (Tripartite Motif Containing 13 (TRIM13))
-
Autre désignation
- TRIM13 / RNF77
-
Sujet
- TRIM13 is an E3 ubiquitin ligase involved in the retrotranslocation and turnover of membrane and secretory proteins from the ER through a set of processes named ER-associated degradation (ERAD). This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins. TRIM13 enhances ionizing radiation-induced p53/TP53 stability and apoptosis via ubiquitinating MDM2 and AKT1 and decreasing AKT1 kinase activity through MDM2 and AKT1 proteasomal degradation, regulates ER stress-induced autophagy, and may act as a tumor suppressor.Synonyms: B-cell chronic lymphocytic leukemia tumor suppressor Leu5, LEU5, Leukemia-associated protein 5, Putative tumor suppressor RFP2, RFP2, RING finger protein 77, Tripartite motif-containing protein 13
-
ID gène
- 10206
-
NCBI Accession
- NP_005789
Antigène
-